Risk of pneumonia with different inhaled corticosteroids in COPD patients: a meta-analysis
Q Zhang, S Li, W Zhou, X Yang, J Li… - COPD: Journal of …, 2020 - Taylor & Francis
ICS are anti-inflammatory agents which have been suggested to benefit people with
worsening symptoms of COPD, by improving lung function, reducing exacerbation of …
worsening symptoms of COPD, by improving lung function, reducing exacerbation of …
Risk of Pneumonia with Different Inhaled Corticosteroids in COPD Patients: A Meta-Analysis.
Q Zhang, S Li, W Zhou, X Yang, J Li, J Cao - COPD, 2020 - europepmc.org
ICS are anti-inflammatory agents which have been suggested to benefit people with
worsening symptoms of COPD, by improving lung function, reducing exacerbation of …
worsening symptoms of COPD, by improving lung function, reducing exacerbation of …
Risk of Pneumonia with Different Inhaled Corticosteroids in COPD Patients: A Meta-Analysis
Q Zhang, S Li, W Zhou, X Yang, J Li, J Cao - COPD, 2020 - pubmed.ncbi.nlm.nih.gov
ICS are anti-inflammatory agents which have been suggested to benefit people with
worsening symptoms of COPD, by improving lung function, reducing exacerbation of …
worsening symptoms of COPD, by improving lung function, reducing exacerbation of …